<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Calderone CT</submitter><funding>NIAID NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>835-46</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2084360</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(7)</volume><pubmed_abstract>Several polyketide secondary metabolites are predicted to undergo isoprenoid-like beta-alkylations during biosynthesis. One such secondary metabolite is myxovirescin A1, produced by Myxococcus xanthus. Myxovirescin is of special interest in that it appears to undergo two distinct beta-alkylations. Additionally, the myxovirescin biosynthetic gene cluster lacks tandem thiolation domains required in the synthesis of other beta-branched secondary metabolites. To probe the origins of the beta-branches in myxovirescin, we heterologously overexpressed the proteins predicted to be responsible for myxovirescin beta-alkylation and reconstituted their activities in vitro on model substrates. Our results confirm that myxovirescin undergoes two isoprenoid-like beta-alkylations during its biosynthesis, </pubmed_abstract><journal>Chemistry &amp; biology</journal><pubmed_title>Incorporation of nonmethyl branches by isoprenoid-like logic: multiple beta-alkylation events in the biosynthesis of myxovirescin A1.</pubmed_title><pmcid>PMC2084360</pmcid><funding_grant_id>GM067725</funding_grant_id><funding_grant_id>GM073323</funding_grant_id><funding_grant_id>AI042738</funding_grant_id><funding_grant_id>R01 AI042738</funding_grant_id><funding_grant_id>F32 GM020011</funding_grant_id><funding_grant_id>F32 GM073323</funding_grant_id><funding_grant_id>GM020011</funding_grant_id><funding_grant_id>GM081743</funding_grant_id><funding_grant_id>R01 GM020011</funding_grant_id><funding_grant_id>F32 GM081743</funding_grant_id><funding_grant_id>R01 GM067725</funding_grant_id><pubmed_authors>Iwig DF</pubmed_authors><pubmed_authors>Walsh CT</pubmed_authors><pubmed_authors>Dorrestein PC</pubmed_authors><pubmed_authors>Kelleher NL</pubmed_authors><pubmed_authors>Calderone CT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Incorporation of nonmethyl branches by isoprenoid-like logic: multiple beta-alkylation events in the biosynthesis of myxovirescin A1.</name><description>Several polyketide secondary metabolites are predicted to undergo isoprenoid-like beta-alkylations during biosynthesis. One such secondary metabolite is myxovirescin A1, produced by Myxococcus xanthus. Myxovirescin is of special interest in that it appears to undergo two distinct beta-alkylations. Additionally, the myxovirescin biosynthetic gene cluster lacks tandem thiolation domains required in the synthesis of other beta-branched secondary metabolites. To probe the origins of the beta-branches in myxovirescin, we heterologously overexpressed the proteins predicted to be responsible for myxovirescin beta-alkylation and reconstituted their activities in vitro on model substrates. Our results confirm that myxovirescin undergoes two isoprenoid-like beta-alkylations during its biosynthesis, </description><dates><release>2007-01-01T00:00:00Z</release><publication>2007 Jul</publication><modification>2026-05-02T20:53:36.607Z</modification><creation>2019-03-27T02:22:00Z</creation></dates><accession>S-EPMC2084360</accession><cross_references><pubmed>17656320</pubmed><doi>10.1016/j.chembiol.2007.06.008</doi></cross_references></HashMap>